Minimally invasive surgery for rectal cancer inflammation
Part of Cancer, Digestive system, Immune system & allergy clinical trials.
This study looks at how different types of surgery (open, laparoscopic, or robotic) affect inflammation throughout the body in people with rectal cancer. It may help doctors understand which approach is gentler on your immune system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with rectal cancer and will have surgery to remove it.
- Your surgery will be either open, laparoscopic, or robotic.
- You do not have a known immune deficiency, like HIV or a condition that weakens your immune system.
- You have not had rectal cancer come back after previous treatment.
- You do not have another type of cancer at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a robotic, top-down approach to remove certain rectal tumors using an intersphincteric resection (a surgery that preserves bowel control as much as possible). It may help some people with stage I–III rectal cancer avoid a bigger operation and improve outcomes compared with standard surgical methods.
This study follows real-world treatment of locally advanced rectal cancer (cancer that has grown into nearby tissues but hasn't spread to distant organs) in patients who receive chemotherapy and/or radiation before surgery. Researchers track how different treatment approaches work to help improve outcomes.
This trial looks at whether removing the rectal tumor locally (through the anus) can work as well as a more extensive operation after scans show no remaining cancer. It may help some people avoid bigger surgery if the cancer truly appears gone after treatment.
This study looks at patient-reported outcomes—how you feel and function—after surgery for rectal cancer. It may help doctors better understand recovery and well-being after different surgical approaches and treatments.
This trial tests whether a full course of chemotherapy and radiation before any surgery (called total neoadjuvant therapy) can help you avoid surgery and preserve your rectum. It is for people with a specific early stage of rectal cancer that has not spread.
This study compares two types of minimally invasive surgery—robotic and laparoscopic—for people with inflammatory bowel disease (Crohn's or ulcerative colitis) who need elective colon or rectal surgery. It aims to find out which approach might be better for recovery and outcomes.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.